Publications

Export 10 results:
Sort by: Author Title Type [ Year (Desc)]
2018
Labib, J. R., S. K. Ibrahem, H. M. Sleem, and M. M. Ismail, Diagnostic indicator of acute lung injury for pediatric critically ill patients at a tertiary pediatric hospital, , 2018. diagnostic_indicator_of_acute_lung_injury.pdf
Ismail, M. M., A. A. Ibrahim, and A. M. Gamal, Salivary Glucose Monitoring Versus Interstitial Glucose Monitoring in Patients with Type 1 Diabetes Mellitus, , 2018. salivary_glucose.pdf
2017
Ismail, M. M., S. kamal Ibrahim, and A. S. A. Ibrahim2, Urinary Smad1 as a New Biomarker for Diabetic Nephropathy in Patients with Type 1 Diabetes Mellitus, , 2017. urinary-smad1-as-a-new-biomarker-for-diabetic-nephropathy-in-patients-with-type-1-diabetes-mellitus-2155-6156-1000756.pdf
Ismail, M. M., S. kamal Ibrahim, and A. S. A. Ibrahim2, Urinary Smad1 as a New Biomarker for Diabetic Nephropathy in Patients with Type 1 Diabetes Mellitus, , 2017. urinary-smad1-as-a-new-biomarker-for-diabetic-nephropathy-in-patients-with-type-1-diabetes-mellitus-2155-6156-1000756.pdf
2016
Fayeda, E. N., N. M. El-Fayoumya, M. M. Al-Kanishy, and H. Mohammed, Multifocal visual evoked potential normative scaling in Egyptian adolescents, , 2016. multifocal_visual_evoked_potential.pdf
Ismail, M. M., T. A. A. Hamid, A. A. Ibrahim, and huda marzouk, Serum adipokines and vitamin D levels in patients with type 1 diabetes mellitus, , 2016. serum_adipokines.pdf
2014
I., M. M., Pediatrics for undergraduates part 1, , Cairo, Elahram commercial press, 2014. 2-_genetics.pdf
I., M. M., pediatrics for undergraduates part 2 , , Cairo, Elahram commercial press, 2014. 6-_hepatology.pdf
2013
I., M. M., Clinical pediatrics for undergraduates, , Cairo, Elahram commercial press, 2013.
2010
I., M. M., M. M. H, N. S. E., and G. A., Role of (Continuous glucose monitoring system) In optimizing glucose level in patients With type 1 diabetes mellitus, , Cairo, Cairo univerity, 2010. Abstract

Role of Continuous glucose monitoring system in optimizing glucose level in patient
With type 1 diabetes mellitus. M.M. Kanishy, N. Salah Eldein, M.M. Hassan and G.M. Anwar
ABSTRACT
OBJECTIVES: The aim of this study is to assess the value of (CGMS) in detection of hypoglycemia, hyperglycemia and the possible role of (CGMS) in facilitating more optimum glucose control in children with type 1 diabetes mellitus.
PATIENTS AND METHODS: A total of 37 compliant children with type 1 diabetes for more than 1 year on intensive insulin therapy (age range 4 -22 years) were included in a non randomized non controlled interventional study for 6 month. The Continuous glucose monitoring system used was the MiniMed Meditronic CGMS gold system, the first model approved by FDA (Food and Drug Administration) and it was not real time CGMS. The CGMS reading were compared to that of SMBG (self monitoring of blood glucose) of at least 6 times a day during the period of study
RESULTS: The average number of hyperglycemic attacks detected by CGMS during the whole monitoring period was 11.7 ± 3, while the average number of hyperglycemic attacks detected by SMBG was 7 ± 2.4. CGMS based adjustment showed a reduction in the average number of hypoglycemic and hyperglycemic attacks with the P value (0.016) and (0.005) respectively. The average HbA1c was reduced significantly from 9.2 ± 1.2% before insulin dose adjustment to 7.8 ± 1.2 and 7.7 ± 1.3% at 3months and 6 months, respectively, after adjustment. The average cholesterol level at the onset was 177.3 ± 44 mg/dl. The cholesterol level was markedly reduced to average value of 161.1 ± 31 mg/dl after 6 months (P 0.000). The mean level of urinary microalbuminuria showed non-significant reduction in the level of urinary microalbuminuria 6 months after adjustment (P 0.112)
CONCLUSIONS: CGMS improved the rate of detection of hypoglycemic and hyperglycemic events. CGMS based adjustment showed marked improvement in glycemic control and in HBA1c values but not in the rates of microalbuminuria